0

Journal Articles

in Thromboembolism/Anticoagulation
 41-60 of 774 Articles
JAMA Neurology | 
Original Contribution |  January 01, 2013
Ischemic Stroke and Transient Ischemic Attack in Young Adults:  Risk Factors, Diagnostic Yield, Neuroimaging, and Thrombolysis
Ruijun Ji, MD, PhD; Lee H. Schwamm, MD; Muhammad A. Pervez, MD; et al.
JAMA Neurol. 2013;70(1):51-57. doi:10.1001/jamaneurol.2013.575.
INCLUDES: CME
JAMA Neurology | 
Correspondence |  January 01, 2013
Weekend Admissions and Increased Risk for Mortality: Less Urgent Treatments Only?
Roberto Manfredini, MD; Fabio Manfredini, MD; Raffaella Salmi, MD; et al.
JAMA Neurol. 2013;70(1):131-133. doi:10.1001/jamaneurol.2013.662.
JAMA Dermatology | 
Study |  January 01, 2013
Retrospective Analysis of Tissue Plasminogen Activator as an Adjuvant Treatment for Calciphylaxis
Rokea A. el-Azhary, MD, PhD; Allison K. Arthur, MD; Mark D. P. Davis, MD; et al.
JAMA Dermatol. 2013;149(1):63-67. doi:10.1001/2013.jamadermatol.5.
JAMA Otolaryngology–Head & Neck Surgery | 
Original Article |  January 01, 2013
Incidence of Venous Thromboembolism in Otolaryngology–Head and Neck Surgery
Frank G. Garritano, MD; Erik B. Lehman, MS; Genevieve A. Andrews, MD
JAMA Otolaryngol Head Neck Surg. 2013;139(1):21-27. doi:10.1001/jamaoto.2013.1049.
JAMA | 
Users' Guides to the Medical Literature |  December 26, 2012
How to Use a Noninferiority Trial:  Users' Guides to the Medical Literature
Sohail M. Mulla, BHSc; Ian A. Scott, MBBS, FRACP, MHA; Cynthia A. Jackevicius, PharmD, MSc; et al.
JAMA. 2012;308(24):2605-2611. doi:10.1001/2012.jama.11235.
JAMA | 
JAMA Patient Page |  December 19, 2012 FREE
Air Travel–Related Deep Vein Thrombosis and Pulmonary Embolism
Harvey J. Sugerman, MD; Bo G. Eklöf, MD; William D. Toff, MD; et al.
JAMA. 2012;308(23):2531. doi:10.1001/jama.2012.4098.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Original Investigation |  December 10, 2012
Enoxaparin Outcomes in Patients With Moderate Renal Impairment
Douglas D. DeCarolis, PharmD; Joey G. Thorson, PharmD; Megan A. Clairmont, PharmD; et al.
Arch Intern Med. 2012;172(22):1713-1718. doi:10.1001/2013.jamainternmed.369.
INCLUDES: CME
JAMA Internal Medicine | 
Invited Commentary |  December 10, 2012
Moderate Renal Impairment and Risk of Bleeding With Anticoagulation:  Comment on “Enoxaparin Outcomes in Patients With Moderate Renal Impairment”
Tracy Minichiello, MD
Arch Intern Med. 2012;172(22):1718-1720. doi:10.1001/2013.jamainternmed.456.
JAMA Neurology | 
Original Contribution |  December 01, 2012
Stroke From Acute Cervical Internal Carotid Artery Occlusion:  Treatment Results and Predictors of Outcome
Raymond C. S. Seet, MD; Eelco F. M. Wijdicks, MD, PhD; Alejandro A. Rabinstein, MD
Arch Neurol. 2012;69(12):1615-1620. doi:10.1001/archneurol.2012.2569.
INCLUDES: CME , Supplemental Content
JAMA | 
Editorial |  November 28, 2012
Warfarin After Bioprosthetic Aortic Valve Implantation
Shamir R. Mehta, MD, MSc; Jeffrey I. Weitz, MD
JAMA. 2012;308(20):2147-2148. doi:10.1001/jama.2012.91476.
JAMA | 
Original Contribution |  November 28, 2012 FREE
Association of Warfarin Therapy Duration After Bioprosthetic Aortic Valve Replacement With Risk of Mortality, Thromboembolic Complications, and Bleeding
Charlotte Mérie, MD; Lars Køber, MD, DMSc; Peter Skov Olsen, MD, DMSc; et al.
JAMA. 2012;308(20):2118-2125. doi:10.1001/jama.2012.54506.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Invited Commentary |  November 26, 2012
Will Newer Anticoagulants Improve Therapy Persistence?:  Comment on “Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation”
Whitney Maxwell, PharmD, BCPS; Charles L. Bennett, MD, PhD, MPP
Arch Intern Med. 2012;172(21):1689-1690. doi:10.1001/2013.jamainternmed.616.
JAMA Internal Medicine | 
Research Letters |  November 26, 2012
Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation
Tara Gomes, MHSc; Muhammad M. Mamdani, PharmD, MA, MPH; Anne M. Holbrook, MD, PharmD, MSc, FRCPC; et al.
Arch Intern Med. 2012;172(21):1687-1689. doi:10.1001/archinternmed.2012.4485.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Editor's Correspondence |  November 26, 2012
Administrative Databases and Trends in In-Hospital Deaths in Pulmonary Embolism
Abhishek Deshmukh, MD; Gagan Kumar, MD
Arch Intern Med. 2012;172(21):1694. doi:10.1001/2013.jamainternmed.43.
JAMA Internal Medicine | 
Invited Commentary |  November 12, 2012
No Place for Novel Oral Anticoagulants in Current Treatment of Acute Coronary Syndromes:  Comment on “Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an Acute Coronary Syndrome”
Adrian V. Hernandez, MD, PhD
Arch Intern Med. 2012;172(20):1546-1547. doi:10.1001/2013.jamainternmed.293.
JAMA Internal Medicine | 
Review Article |  November 12, 2012
Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an Acute Coronary Syndrome:  Systematic Review and Meta-analysis of Randomized Controlled Trials
András Komócsi, MD, PhD; András Vorobcsuk, MD, PhD; Dániel Kehl, MS; et al.
Arch Intern Med. 2012;172(20):1537-1545. doi:10.1001/archinternmed.2012.4026.
INCLUDES: , Supplemental Content
JAMA | 
Medical News and Perspectives |  November 07, 2012
New Anticoagulants Offer Options Beyond Warfarin to Reduce Stroke Risk
Mike Mitka, MSJ
JAMA. 2012;308(17):1727-1728. doi:10.1001/jama.2012.14623.
JAMA Neurology | 
Original Contribution |  November 01, 2012
Low-Molecular-Weight Heparin and Early Neurologic Deterioration in Acute Stroke Caused by Large Artery Occlusive Disease
Qiaoshu Wang, MD; Christopher Chen, FRCP; Xiang Yan Chen, MD; et al.
Arch Neurol. 2012;69(11):1454-1460. doi:10.1001/archneurol.2012.1633.
INCLUDES: CME
JAMA Surgery | 
Invited Critique |  November 01, 2012
Venous Thromboembolism Prophylaxis: One Size Does Not Fit All:  Comment on “Comparative Effectiveness of Unfractionated and Low-Molecular-Weight Heparin for Prevention of Venous Thromboembolism Following Bariatric Surgery”
M. Margaret Knudson, MD
Arch Surg. 2012;147(11):998-999. doi:10.1001/archsurg.2012.2318.
JAMA Surgery | 
Original Article |  November 01, 2012
Comparative Effectiveness of Unfractionated and Low-Molecular-Weight Heparin for Prevention of Venous Thromboembolism Following Bariatric Surgery
Nancy J. O. Birkmeyer, PhD; Jonathan F. Finks, MD; Arthur M. Carlin, MD; et al.
Arch Surg. 2012;147(11):994-998. doi:10.1001/archsurg.2012.2298.
INCLUDES: CME

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Editor's Correspondence  |  June 10, 2013
Additional Considerations to Precede Selection of Enoxaparin Therapy
Marta A. Miyares, PharmD, BCPS (AQ Cardiology)
JAMA Internal Medicine
Editor's Correspondence  |  June 10, 2013
Additional Considerations to Precede Selection of Enoxaparin Therapy—Reply
Douglas D. DeCarolis, PharmD; Gerhard J. Johnson, MD
JAMA Neurology
Images in Neurology  |  June 10, 2013
Extensive Cerebral Venous Thrombosis
Sarah Nelson, MD; Bryan Ho, MD
JAMA Surgery
Viewpoint  |  June 5, 2013
The Nonattending Physician
Leland Albright, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems